EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study

P Goadsby, D Dodick, E Spierings, J Scherer, S Sweeney, D Grayzel
2014 The Journal of Headache and Pain  
doi:10.1186/1129-2377-15-s1-g10 fatcat:7hl4smqzlrgibh2my3lqcx4jhm